Moody's Ratings Affirms Renault's Ba1 rating, changes outlook to posit...

Moody's Ratings (Moody's) has today affirmed all ratings of Renault S.A. (Renault or the group) including its Ba1 long-term corporate family rating (CFR), its Ba1-PD probability of default rating (PDR), the (P)Ba1 rating of its senior unsecured EMTN programme and the Ba1 rating of the group's senior...

Just Kickin' It, Monthly Sneaker Tracker, May'24 Edition

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/08/2024

...

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 08/05/2024

...

Morning Notes : ABI BB, AD NA, BEKB BB, EURN BB, GBLB BB, MONT BB, SOL...

: ABI BB, AD NA, BEKB BB, EURN BB, GBLB BB, MONT BB, SOLB BB, MAAT FP

Solvay Model update post 1Q, reconfirming our BUY rating

We upped our FY24 adjusted EBITDA forecast by 2% following the better than expected 1Q24 results. After the recent spun off of Syensqo, Solvay is a base chemicals group with leading market and technology positions in the vast majority of its businesses. The company will be managed with a conservative financial approach, favouring dividends over aggressive growth and operating with a solid balance sheet (1.4x leverage). The stable to growing dividend flow implies a solid 7% dividend yield. Other ...

AstraZeneca : A consensus that leaves little room for surprising guida...

>The premium can be justified by short-term growth and a well-stocked pipeline - AZN certainly benefits from: i/ attractive short-term core EPS growth for 2023-2027, up 11.5% (+12.7% expected this year), and undoubtedly the most well-stocked pipeline in the industry. These elements partly justify the market premium for its 2025 P/E (+43% vs sector median), leading to a 2023-2027 PEG of 1.6x vs 1.3x for the sector. However, this growth should be more timorous in 2...

AstraZeneca : Un consensus qui ne laisse que peu de place à une guidan...

>Une prime qui se justifie par une croissance CT et un pipeline exhaustif - AZN bénéficie sans nulle doute i/ d’une croissance CT attractive Core BPA 2023-2027 en hausse de 11.5% (+12.7% att cette année) et d’un pipeline certainement le plus exhaustif de l’industrie. Ces aspects justifient en partie la prime octroyée par le marché en termes de PE 25e (+43% vs médiane sectorielle) conduisant à un PEG 23/27e de 1.6x vs 1.3x pour le secteur. En revanche cette croiss...

Geberit AG : Un début d’année plutôt rassurant, grâce à un début de re...

>T1 2024 : un EBITDA 5.2% au-dessus des attentes et une marge à 32.8% - Le groupe a publié hier matin des résultats T1 supérieurs aux attentes. Le chiffre d’affaires a reculé de 1.4% à changes constants (consensus -4.0%), dont -2% de volumes/mix et +1% d’effet prix. La marge d’EBITDA atteint 32.8%, -30 pb, portant l’EBITDA à 275 MCHF (consensus à 261 MCHF). Le groupe souligne notamment avoir bénéficié d’un effet prix (net de l’inflation des prix des matières premières...

Geberit AG : A generally reassuring start to the year thanks to the be...

>Q1 2024: EBITDA 5.2% above expectations and a margin of 32.8% - Yesterday morning, the group reported Q1 results that beat expectations. Sales were down 1.4% at constant exchange rates (consensus -4.0%), with -2% for volumes/mix and a +1% price effect. The EBITDA margin was 32.8%, down -30bp, bringing EBITDA to CHF 275m (consensus CHF 261m). The group highlighted notably that it had benefited from a favourable price effect (net of inflation in raw materials prices) o...

Solvay Conference call feedback

Below are the highlights from the conference call. 1Q underlying EBITDA dropped by 13.6% organically to 265m which was 13% better than our forecast and 12% above CSS. Solvay reiterated its FY uEBITDA guidance which calls for a 10-20% organic decline vs the restated 2023 base. After the recent spun off of Syensqo, Solvay is a base chemicals group with leading market and technology positions in the vast majority of its businesses. The company will be managed with a conservative financial approach...

Credit Morning 05/07/2024

Monte has published a solid Q1 2024 results, above expectationsClariane has received a put option agreement for its HAD/SSIAD activities in FranceZalando: FY targets confirmed following a better-than-expected Q1, plans to buy back up to € 100m of convertible bonds due 2025Banco Sabadell rejects BBVA’s proposal>...

Morning Crédit 07/05/2024

Monte publie un T1 2024 solide, au-dessus des attentesZalando : objectifs confirmés à l’issue d’un T1 supérieur aux attentes, envisage des rachats d’obligations convertibles 2025 pour 100 m EUR maximumClariane a reçu une offre pour la cession de ses activités HAD/SSIAD en FranceBanco Sabadell rejette la proposition de fusion de BBVA>...

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/07/2024

...

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 07/05/2024

...

Zalando : Q1 profits above forecasts, FY 2024 targets confirmed

>GMV and revenue flat in Q1, adjusted EBIT margin up 130bp - In Q1, GMV was up 1% y-o-y to € 3,270m (consensus: € 3,242m, ODDO BHFe: € 3,268m) and sales decreased 1% to € 2,241m (consensus: € 2,262m, ODDO BHFe: € 2,267m), i.e. both were in line with consensus expectations. B2C revenue was down 2% while B2B revenue increased by 13%. Adjusted EBIT came in at € 28m (consensus: € 20m, ODDO BHFe: € 20m) with a margin of 1.3% (up 130bp) thanks to materially lower fulfilment...

Benelux Morning Notes

Adecco: 1Q24 in line; stable trends into 2Q24. Arcadis: Interesting contract in Ontario. NSI: Further comments on the First Sponsor move. Philips: Healthineers reports 2Q24 update. Solvay: Solid 1Q24 EBITDA beat, FY consensus looks rather cautious now

Morning Notes : GBLB BB, SOLB BB

: GBLB BB, SOLB BB